Please login to the form below

Not currently logged in
Email:
Password:

American College of Cardiology

This page shows the latest American College of Cardiology news and features for those working in and with pharma, biotech and healthcare.

Sanofi, Regeneron offer price cut for cholesterol drug Praluent

Sanofi, Regeneron offer price cut for cholesterol drug Praluent

The offer has been made just after the presentation of the large-scale ODYSSEY OUTCOMES at the American College of Cardiology (ACC) meeting in Orlando, which showed that adding PCSK9 inhibitor ... be acceptable for the drug – depending on the

Latest news

  • AZ data suggest SGLT2 inhibitors can reduce heart failure risk AZ data suggest SGLT2 inhibitors can reduce heart failure risk

    The CVD-REAL study – presented at the American College of Cardiology (ACC) meeting in Washington DC - examined patient records from 300, 000 people across six countries and found that treatment with ... patients with type 2 diabetes at the lower end of

  • Xarelto beats aspirin for recurrent blood clots Xarelto beats aspirin for recurrent blood clots

    Xarelto beats aspirin for recurrent blood clots. Trial shows the NOAC reduces the risk of blood clots by 74%. ... The results were presented at the American College of Cardiology (ACC) meeting in Washington DC by Philip Wells of the University of Ottawa

  • Novartis launches heart failure social network Novartis launches heart failure social network

    To that end the company worked with several US health advocacy organisations to set up Together in HF, among them the American Association of Heart Failure Nurses, CardioSmart by the American ... College of Cardiology and WomenHeart: The National

  • Cholesterol drugs could have striking benefits in stroke Cholesterol drugs could have striking benefits in stroke

    hypothesis that lipid lowering may be effective in the primary prevention of stroke in older people.”. ... This followed 2013 guidelines from the American Heart Association and American College of Cardiology calling for a more nuanced approach to

  • AZ seeks leg up in antiplatelet market with Brilinta antidote AZ seeks leg up in antiplatelet market with Brilinta antidote

    AZ's drug is now considered the preferred oral antiplatelet drug by the American Heart Association (AHA) and American College of Cardiology (ACC), and having an effective reversal agent could encourage ... on the road to meeting AZ's sales target of

More from news
Approximately 2 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • Interview: Allan Hillgrove, Boehringer Interview: Allan Hillgrove, Boehringer

    This interest in China expands beyond Lilly and diabetes, however, and Boehringer's additional efforts include educational partnerships, such as a joint effort with the Chinese Society of Cardiology and the ... American College of Cardiology (ACC) to

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • New head at Cardiovascular Research Foundation New head at Cardiovascular Research Foundation

    New head at Cardiovascular Research Foundation. Jack Lewin is former CEO of American College of Cardiology and the California Medical Association. ... A former CEO of both the American College of Cardiology and the California Medical Association, Lewin

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics